New drug combo offers hope for bladder cancer patients who failed standard therapy

This study tests a new treatment for people with a high-risk type of bladder cancer that did not get better after standard BCG therapy. The treatment combines two chemotherapy drugs placed directly into the bladder with an immunotherapy drug given through a vein. The goal is to see if this combination can make the cancer disappear and to check for side effects. About 37 adults will take part.